These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11028328)

  • 21. Implications of the recent clinical trials in hypertension.
    Moser M
    N Y State J Med; 1987 Jan; 87(1):5-6. PubMed ID: 3550545
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experience with angiotensin II antagonists in arterial hypertension].
    Salvetti A; Virdis A
    Cardiologia; 1994 Dec; 39(12 Suppl 1):405-8. PubMed ID: 7634305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ambulatory blood pressure monitoring and clinical trials].
    Andréjak M; Mallion JM; Asmar R; Chau NG; de Gaudemaris R; Drici M; Herpin D; Poncelet P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1175-8. PubMed ID: 8572868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
    van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
    Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications and controversies of recent hypertension trials.
    Schwartz ML
    J Am Coll Cardiol; 2006 Aug; 48(4):848-9; author reply 849-50. PubMed ID: 16904567
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic implications from clinical trials for the treatment of hypertension.
    Kaplan NM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):22S-27S. PubMed ID: 3540225
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevention of atherosclerosis and end-organ damage: a basis for antihypertensive interventional strategies.
    Schwartz CJ; Valente AJ; Hildebrandt EF
    J Hypertens Suppl; 1994 Jul; 12(5):S3-11. PubMed ID: 7965284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of ambulatory blood pressure monitoring in the evaluation of the therapeutic efficacy of antihypertensive drugs. Trough/peak relation].
    Nobre F
    Arq Bras Cardiol; 1995 Mar; 64(3):247-9. PubMed ID: 7487513
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypertension and insulin resistance: mechanisms an implications for treatment.
    Dodson PM
    J Hum Hypertens; 1991 Oct; 5(5):349-54. PubMed ID: 1770464
    [No Abstract]   [Full Text] [Related]  

  • 30. Discrepancies between use of antihypertensive drugs and guidelines indications: pharmacoeconomic implications.
    Robbiano L; Martelli A; Brambilla G
    J Hum Hypertens; 2005 Oct; 19(10):819-22. PubMed ID: 15951739
    [No Abstract]   [Full Text] [Related]  

  • 31. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive effects of trandolapril and nitrendipine in the elderly: a controlled trial with special emphasis on time effect profiles.
    Zannad F; Vaur L; Dutrey-Dupagne C; Genes N; Clerson P
    J Hum Hypertens; 1996 Jan; 10(1):51-5. PubMed ID: 8642191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacological basis of the clinical use of antihypertensive agents].
    Ménard J; Alexandre JM; Milliez P
    Coeur Med Interne; 1972; 11(1):69-74. PubMed ID: 5014853
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of antihypertensive therapy on the hemodynamics of hypertension: clinical implications.
    Lund-Johansen P
    Clin Ther; 1986; 8(4):382-97. PubMed ID: 3524841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differential efficacy of antihypertensive agents in the elderly.
    Tuck M; Janssens M
    J Hum Hypertens; 1990 Aug; 4(4):415-20. PubMed ID: 2258887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical implications of trough to peak ratio].
    Hasebe N; Kikuchi K
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():224-7. PubMed ID: 11028328
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications].
    Polónia J
    Rev Port Cardiol; 1996 Apr; 15(4):281-92. PubMed ID: 8814671
    [No Abstract]   [Full Text] [Related]  

  • 39. Antihypertensive effect of drugs: statistical distribution of the trough-to-peak ratio.
    Chi VX; Chau NP
    Biometrics; 1996 Mar; 52(1):286-90. PubMed ID: 8934597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect].
    Parati G; Omboni S; Mancia G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):345-8. PubMed ID: 12497932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.